It is currently Sun Aug 28, 2016 11:55 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Amiselimod study shows ‘promising results’

New research has found that Amiselimod “significantly” reduces the number of MS-related lesions found in various brain areas...Read more - http://www.ms-uk.org/amiselimod-study-shows-%E2%80%98promising-results%E2%80%99-250816
Read more : Amiselimod study shows ‘promising results’ | Views : 135 | Replies : 0 | Forum : General Discussion


RebiSmart device ‘improves adherence to MS therapy’

People with relapsing multiple sclerosis who use a device called RebiSmart to self-inject medications like Rebif are more likely to take their therapies regularly and adhere to a schedule, resulting in fewer relapses compared to those not using the device, according to a study by researchers in Spain...Read more - http://www.ms-uk.org/rebismart-device-%E2%80%98improves-adherence-ms-therapy%E2%80%99-250816
Read more : RebiSmart device ‘improves adherence to MS therapy’ | Views : 83 | Replies : 0 | Forum : Rebif


Novartis announces positive results for Siponimod

Novartis AG has said that a late-stage study has shown the oral, once-daily BAF312 drug, or Siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis...Read more - http://www.ms-uk.org/novartis-announces-positive-results-siponimod-250816
Read more : Novartis announces positive results for Siponimod | Views : 109 | Replies : 0 | Forum : General Discussion


should CIS be considered MS?

Should CIS be considered MS? If we assume that MS is the presence of multiple scars, just one lesion should not be considered MS.

On the other hand, normally MS refers the underlying condition that produces the scars. From this point of view CIS should be inside MS when is expected to evolve into clinical MS.

What do you think? What should be the proper way to classify CIS?
Read more : should CIS be considered MS? | Views : 156 | Replies : 0 | Forum : General Discussion


THERE IS NO MONEY IN THE CURE!

Day after day, I read through MS chat rooms, to find something that would give me hope...but it has been over 20 Years that I have had MS, and the truth is that NOTHING works and that NOTHING new has been developed. I am still on the some interferon, not because it works, but because it is profitable for drug companies. Furthermore, it is highly profitable for the Government too, as they get to tax ...
Read more : THERE IS NO MONEY IN THE CURE! | Views : 388 | Replies : 9 | Forum : General Discussion


Umbilical cord shows promise in cell therapy

A cell therapy product derived from human umbilical cord blood cells may be a promising treatment approach for patients with demyelinating conditions, such as multiple sclerosis (MS) or leukodystrophy, according to a recent study developed at the Duke University Medical Center...Read more - http://www.ms-uk.org/umbilical-cord-shows-promise-cell-therapy-230816
Read more : Umbilical cord shows promise in cell therapy | Views : 134 | Replies : 0 | Forum : Stem Cells


“If You See Something, Say Something”

Editorial by Deborah Sweet on encouraging readers to take action on stem cell clinics.
(Cell Stem Cell)

http://www.cell.com/cell-stem-cell/full ... %2930209-0
Read more : “If You See Something, Say Something” | Views : 165 | Replies : 0 | Forum : Stem Cells


The story of Rituxan and the weakest point in the system

Maybe some of you have heard about the history of Rituxan and Ocrelizumab. Ocrelizumab is a slightly modified version of Rituxan/Rituximab. As Rituxan was approaching FDA approval for treatment of multiple sclerosis (with very good results), it was also approaching the end of its patent. Therefore the company decided that it was not profitable to pursue the approval process for a treatment that would be available soon from other productors.

The history is explained by ...
Read more : The story of Rituxan and the weakest point in the system | Views : 136 | Replies : 0 | Forum : General Discussion


Researchers link MS risk genes to Vitamin D

The further away you live from the equator, apparently the more likely you are to be diagnosed with MS. It sounds simple, but since analysis of the genetic determiners of multiple sclerosis began in the '70s, sunlight's factoring in the disease has seemed irreconcilable with its highly complex genetic make-up...Read more - http://www.ms-uk.org/researchers-link-ms-risk-genes-vitamin-d-220816
Read more : Researchers link MS risk genes to Vitamin D | Views : 132 | Replies : 0 | Forum : General Discussion


7 Tesla MRI demonstrates vascular pathology in Baló’s concen

Any thoughts about this??

7 Tesla MRI demonstrates vascular pathology in Baló’s concentric sclerosis

http://msj.sagepub.com/content/19/1/120.abstract


Abstract

Baló’s concentric sclerosis (BCS) is an inflammatory demyelinating disease related to multiple sclerosis; its underlying pathology remains unclear. At 7 T MRI in a 19-year-old female BCS patient, microhaemorrhages and ectatic veins were found in T2 hyperintense regions, features which have not been previously reported in conjunction with BCS, and these findings may ...


 

Login  •  Register


Statistics

Total posts 233928 • Total topics 25128 • Total members 16304


Contact us | Terms of Service